|
AKTX
|
Akari Therapeutics Plc
|
US
|
NASDAQ
|
|
APLS
|
Apellis Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
AZN
|
Astrazeneca PLC
|
US
|
NASDAQ
|
|
CMMB
|
ChemomAb Therapeutics Ltd.
|
US
|
NASDAQ
|
|
CYCC
|
Cyclacel Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CYCCP
|
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock
|
US
|
NASDAQ
|
|
DVAX
|
Dynavax Technologies Corporation
|
US
|
NASDAQ
|
|
IDRA
|
Idera Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
34LA
|
Alpine Immune Sciences Inc
|
DE
|
F
|
|
CANTA
|
Cantargia AB
|
SE
|
ST
|
|
QTTB
|
Q32 Bio Inc
|
US
|
US
|
|
1JK
|
APELLIS PHARMACT.DL-0001
|
DE
|
F
|
|
1K0
|
IGM BIOSCIENCES DL-01
|
DE
|
F
|
|
1UC
|
Cue Biopharma Inc
|
DE
|
F
|